Discontinuation of neoadjuvant therapy does not influence postoperative short-term outcomes in elderly patients (≥ 70 years) with resectable gastric cancer: a population-based study from the dutch upper gastrointestinal cancer audit (DUCA) data

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

Article  CAS  PubMed  Google Scholar 

van der Veen A, Brenkman HJF, Seesing MFJ, Haverkamp L, Luyer MDP, Nieuwenhuijzen GAP, et al. Laparoscopic Versus Open Gastrectomy for Gastric Cancer (LOGICA): A Multicenter Randomized Clinical Trial. J Clin Oncol. 2021;39(9):978–89.

Article  PubMed  Google Scholar 

Haverkamp L, Brenkman HJ, Seesing MF, Gisbertz SS, van Berge Henegouwen MI, Luyer MD, et al. Laparoscopic versus open gastrectomy for gastric cancer, a multicenter prospectively randomized controlled trial (LOGICA-trial). BMC Cancer. 2015;15:556. https://doi.org/10.1186/s12885-015-1551-z.

Article  PubMed  PubMed Central  Google Scholar 

Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11–20.

Article  CAS  PubMed  Google Scholar 

Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet (London, England). 2019;393(10184):1948–57.

Article  PubMed  Google Scholar 

Ychou M, Boige V, Pignon JP, Conroy T, Bouché O, Lebreton G, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011;29(13):1715–21. https://doi.org/10.1200/jco.2010.33.0597.

Article  CAS  PubMed  Google Scholar 

Coccolini F, Nardi M, Montori G, Ceresoli M, Celotti A, Cascinu S, et al. Neoadjuvant chemotherapy in advanced gastric and esophago gastric cancer Meta analysis of randomized trials. Int J Surg. 2018. https://doi.org/10.1016/j.ijsu.2018.01.008.

Article  PubMed  Google Scholar 

Joharatnam-Hogan N, Shiu KK, Khan K. Challenges in the treatment of gastric cancer in the older patient. Cancer Treatment Rev. 2020;85:101980. https://doi.org/10.1016/j.ctrv.2020.101980.

Article  Google Scholar 

Wu C, Wang N, Zhou H, Wang T, Mao Q, Zhang X, et al. Effects of Neoadjuvant Chemotherapy Toxicity and Postoperative Complications on Short-term and Long-term Outcomes After Curative Resection of Gastric Cancer. J Gastrointest Surg. 2020;24(6):1278–89.

Article  PubMed  Google Scholar 

Robb WB, Messager M, Goere D, Pichot-Delahaye V, Lefevre JH, Louis D, et al. Predictive factors of postoperative mortality after junctional and gastric adenocarcinoma resection. JAMA Surg. 2013;148(7):624–31.

Article  PubMed  Google Scholar 

Robb WB, Messager M, Gronnier C, Tessier W, Hec F, Piessen G, et al. High-Grade Toxicity to Neoadjuvant Treatment for Upper Gastrointestinal Carcinomas: What is the Impact on Perioperative and Oncologic Outcomes? Ann Surg Oncol. 2015;22(11):3632–9.

Article  PubMed  Google Scholar 

Busweiler LA, Wijnhoven BP, van Berge Henegouwen MI, Henneman D, van Grieken NC, Wouters MW, et al. Early outcomes from the Dutch Upper Gastrointestinal Cancer Audit. Br J Surg. 2016;103(13):1855–63.

Article  CAS  PubMed  Google Scholar 

Voeten DM, Busweiler LAD, van der Werf LR, Wijnhoven BPL, Verhoeven RHA, van Sandick JW, et al. Outcomes of Esophagogastric Cancer Surgery During Eight Years of Surgical Auditing by the Dutch Upper Gastrointestinal Cancer Audit (DUCA). Ann Surg. 2021;274(5):866–73.

Article  PubMed  Google Scholar 

Borggreve AS, Kingma BF, Ruurda JP, van Hillegersberg R, Dutch Upper GICA. Safety and feasibility of minimally invasive surgical interventions for esophageal and gastric cancer in the acute setting: a nationwide cohort study. Surg Endoscopy. 2021;35(3):1219–29.

Article  Google Scholar 

Wu Z, Yan S, Liu Z, Jing C, Liu F, Yu J, et al. Postoperative abdominal complications of gastric and colorectal cancer surgeries in China: a multicentered prospective registry-based cohort study. Science bulletin. 2022;67(24):2517–21.

Article  PubMed  Google Scholar 

van der Werf LR, Voeten SC, van Loe CMM, Karthaus EG, Wouters M, Prins HA. Data verification of nationwide clinical quality registries. BJS open. 2019;3(6):857–64.

Article  PubMed  PubMed Central  Google Scholar 

Wang JP, E MG, M RV, M DPL, J PR, van Hillegersberg R. Scientific and rigorous data registration of patients with gastric cancer is the cornerstone of high-quality surgical research on gastric cancer: lessons learned from the Dutch upper gastrointestinal cancer audit (DUCA). Chin J Gastrointest Surg. 2023;26(2):148–53.

CAS  Google Scholar 

Wang Q, Wu ZQ, Liu ZN, Li ZY, Ji JF. Establishment and data quality control of a multicenter prospective database for prevalence of abdominal complications after gastroenterological surgery. Chin J Gastrointest Surg. 2023;26(2):154–9.

CAS  Google Scholar 

Cai Y, Song W, Li J, Jing Y, Liang C, Zhang L, et al. The landscape of aging. Science China Life sciences. 2022;65(12):2354–454.

Article  PubMed  PubMed Central  Google Scholar 

Tu RH, Lin JX, Xie JW, Wang JB, Lu J, Chen QY, et al. Assessment of the short-term outcomes of laparoscopic gastrectomy after neoadjuvant chemotherapy for locally advanced gastric cancer: A prospective single-armed clinical trial. Surgery. 2022;172(1):160–8.

Article  PubMed  Google Scholar 

Terashima M, Iwasaki Y, Mizusawa J, Katayama H, Nakamura K, Katai H, et al. Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG0501). Gastric Cancer. 2019;22(5):1044–52.

Article  CAS  PubMed  Google Scholar 

Liao Y, Yang ZL, Peng JS, Xiang J, Wang JP. Neoadjuvant chemotherapy for gastric cancer: a meta-analysis of randomized, controlled trials. J Gastroenterol Hepatol. 2013;28(5):777–82.

Article  PubMed  Google Scholar 

Wang X, Zhao DB, Yang L, Chi Y, Zhao H, Jiang LM, et al. Preoperative Concurrent Chemoradiotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: Phase II Randomized Study. Front Oncol. 2022;12:870741.

Article  PubMed  PubMed Central  Google Scholar 

Keywani K, Borgstein ABJ, Eshuis WJ, Pape M, Versteeg KS, Derks S, et al. Neoadjuvant chemotherapy in older patients with gastric cancer undergoing surgery: a population-based cohort study. Gastric Cancer. 2023;26(5):763–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif